tDCS对成人代谢综合征参数的影响:系统综述与元分析
A systematic review and meta-analysis exploring the effects of tDCS on metabolic syndrome parameters in adults
研究通过系统综述和元分析,评估了tDCS对代谢综合征相关参数的影响,发现tDCS显著减少了体重和腰围,但对BMI和血糖等指标无显著影响。
Introduction
Metabolic syndrome refers to a group of related conditions closely linked to obesity which predict adverse health outcomes [1]. Metabolic syndrome significantly elevates the risk of cardiovascular morbidity and mortality, with affected individuals exhibiting nearly twice the risk of cardiovascular disease and a fivefold increase in the likelihood of developing type 2 diabetes (T2DM) [1]. The World Health Organization (WHO) established criteria for metabolic syndrome in 1998, targeting both those predisposed to cardiovascular disease and non-diabetic individuals at elevated risk for T2DM [2, 3]. Several definitions have appeared over time, but the differences between them are relatively small [2, 3]. The International Diabetes Federation (IDF) defines it as the presence of central obesity (using ethnicity-specific waist circumference thresholds) together with at least two of the following factors: elevated triglycerides, raised blood pressure, increased fasting plasma glucose, or reduced high-density lipoprotein (HDL) cholesterol levels [4].
The prevalence of obesity and metabolic syndrome has risen in parallel [3], with lower prevalences in people with higher levels of education and income [5]. Estimates from the USA suggest that, if trends in overweight and obesity rates continue, an additional 41.4 million adults will be living with overweight or obesity by 2050 [6]. USA data also show increases in the prevalence of metabolic syndrome since 2011, with rates of 37.6% in 2011–12, and 41.8% in 2017–18 [5]. The prevalence of comorbidities (e.g., diabetes and cardiovascular diseases) associated with this condition has shown a similar upward trend, contributing to significant health consequences [5]. To mitigate this escalating public health challenge, innovative approaches to prevention and treatment are needed.
Metabolic syndrome is multifactorial and can be driven by an imbalance between caloric intake and energy expenditure [3]. It is influenced by genetic predisposition, physical inactivity, dietary habits, and alterations in gut microbiome composition [3]. Although its prevalence parallels that of obesity and T2DM, and some definitions of metabolic syndrome require the presence of central obesity, it can also manifest in individuals without obesity [2, 3]. Therapeutic strategies for managing metabolic syndrome and obesity often share common elements, i.e. interventions targeting one condition can improve the other [7]. In particular, weight loss is a fundamental component in the management of metabolic syndrome, whether achieved through behavioural modification, pharmacotherapy or bariatric surgery [8]. Such interventions have been associated with remission of type T2DM and significant reductions in cardiovascular risk factors such as hypertension and dyslipidaemia [8].
In the past decade, non-invasive brain stimulation (NIBS) techniques have gained increasing attention, with a growing body of research investigating their potential to modify cardiovascular risk factors (e.g., reducing blood pressure) and treat obesity [9]. Transcranial direct current stimulation (tDCS) is one of the least invasive forms of NIBS. It involves application of a weak electric current (typically 0.5–2 mA for 20 min) via scalp electrodes. This induces shifts in neuronal excitability, modulates neural networks [10, 11], and leads to lasting changes in brain function, particularly with repeated administration [12]. Compared to other neuromodulation techniques, tDCS has several advantages, including feasibility for home-based use, the ability to have an effective placebo, bilateral stimulation, affordability, and a favourable safety profile with minimal adverse effects [12, 13].
Evidence suggests that tDCS influences metabolic-related parameters, including blood pressure, blood glucose, and insulin levels [14,15,16]. Increasing evidence has also demonstrated the potential of tDCS to alter eating behaviours, facilitate weight loss, and promote weight maintenance [17,18,19,20,21]. A recent systematic review has reported that active tDCS stimulation was associated with greater average body weight reduction of (−0.82 kg) among individuals with obesity relative to sham stimulation [22]. Based on these reports, tDCS appears to be a promising intervention for addressing obesity-related eating behaviours and weight reduction. However, differences remain in the literature regarding the consistency and magnitude of tDCS effects on metabolic and weight-related outcomes.
Although the mechanisms underlying these effects remain unclear, evidence suggests that targeting frontal brain regions enhances cognitive and inhibitory control, thereby improving obesity-related outcomes [19, 23, 24]. Furthermore, the prefrontal cortex has been identified as a key neural substrate in the regulation of cardiovascular function, with established associations with heart rate and heart rate variability [11]. Accordingly, neuromodulation via tDCS presents a promising approach for the management of metabolic-related syndromes. However, to our knowledge, no systematic review has comprehensively examined the therapeutic effects of tDCS on outcomes specifically associated with metabolic syndrome.
This systematic review and meta-analysis aim to evaluate whether tDCS improves metabolic syndrome-related outcomes. Specifically, it critically assesses the clinical efficacy of tDCS in adults by examining its effects on weight, BMI, waist circumference, blood pressure, blood glucose, insulin, and lipid profile. Where available, secondary outcomes such as eating behaviours, stress-related hormones, mood, leptin, and neuroplasticity markers are included.
Methods
Study design and protocol
This review was performed in accordance with the reporting guidance provided in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [25]. The protocol for this review has been registered within the PROSPERO (registration ID: CRD42023448870).
Search strategy
Two reviewers (MA and ML) independently searched three electronic databases (Embase, PsychInfo and PubMed) from inception until the 20th of March 2026, with the following search terms: ((‘Transcranial direct current stimulatio’ OR ‘tDCS’ OR ‘Neuromodulation’ OR ‘Non-invasive brain stimulation’ OR ‘Transcranial electrical stimulation’) AND (‘Body weight’ OR ‘BMI’ OR ‘Overweight’ OR ‘Obesity’ OR ‘Obesity management’ OR ‘eating behaviour*‘ OR ‘Binge eating’ OR ‘Cholesterol’ OR ‘Triglycerides’ OR ‘Lipid profile’ OR ‘Metabolic syndrome’ OR ‘Hypertension’ OR ‘Blood pressure’ OR ‘Glucose’ OR ‘Insulin’ OR ‘Hb1AC’)).
We prioritised terms related to metabolic-syndrome outcomes (our primary focus) but also included key behavioural terms (eating behaviour and binge eating) and obesity-related terms (‘body weight’, ‘BMI’, and ‘obesity management’) as supplementary search elements. These terms were chosen as they are frequently reported in intervention studies within the obesity and metabolic health literature. This ensured we captured studies that primarily reported metabolic endpoints while still identifying trials that reported eating-behaviour or other behavioural measures alongside those metabolic outcomes.
The secondary search strategy involved checking reference lists of relevant studies and reviews to identify papers for inclusion. Additionally, the search included clinical trial registries such as the International Committee of Medical Journal Editors (ICMJE) registry, the National Institutes of Health (NIH) registry, the European Union (EU) Clinical Trials Register, the World Health Organization (WHO) Clinical Registry and the International Standard Randomised Controlled Trial Number (ISRCTN) registry, dissertation databases. Unpublished data meeting eligibility criteria were included if sufficient information was available.
Eligibility criteria
Studies were selected according to the following eligibility criteria using the PICOS toll [25] detailed below:
• P | population: | Adult participants with or without excess body weight. |
• I | intervention: | Single or multiple sessions of tDCS. |
• C | comparator: | A sham tDCS control group or another intervention in the control group (e.g., treatment as usual). |
• O | outcomes of interest: | Inclusion of at least one metabolic syndrome-specific clinical measure, changes in weight, BMI, waist circumference, blood pressure, blood glucose, insulin, lipid profile. Secondary outcomes included eating behaviours, stress-related hormones, mood, leptin and neuroplasticity markers. |
• S | study design: | Experimental and clinical control studies published in English. |
Selection process and data extraction
After removing duplicates, two reviewers (MA and ML) independently screened titles and abstracts against the eligibility criteria using Rayyan software. Discrepancies identified during the full-text review were resolved through consensus or assessment by a third reviewer (US). In instances where studies included participants recruited from the same population, institution, or time period, only one independent sample was retained. Preference was given to studies reporting the most relevant outcomes for this review. Protocols identified at screening were excluded as primary reports; we searched for matching publications via databases, trial registries, and forward citation searching, and contacted protocol authors by e-mail to request full texts or study data, those protocols for which no full report or data were obtained were excluded.
All papers not meeting the inclusion criteria were excluded, with reasons for exclusion documented (Fig. 1).
PRISMA flow diagram of the systematic review.
The data from all included studies was extracted into a specifically designed electronic summary table by a data extractor MA, which was verified independently by another data extractor (ML). Any discrepancies were resolved through discussion and consensus. The extracted data included:
• P | population: | Age, gender, sample size, study’s inclusion/exclusion criteria, diagnosis, and number of participants who were overweight/obese. |
• I | intervention: | tDCS stimulation lateralisation, current intensity and duration, anode placement, and total number of sessions. |
• C | comparator: | Sham control group, waitlist, and treatment as usual. |
• O | outcomes of interest: | Mean and standard deviation of metabolic syndrome-related parameters at baseline and post-treatment, including weight, BMI, waist circumference, systolic and diastolic blood pressure, blood glucose, insulin, cholesterol, triglycerides, and HDL. Secondary outcomes included eating behaviours, stress-related hormones, mood, leptin, neuroplasticity markers e.g., Brain-Derived Neurotrophic Factor where available. |
• S | study design: | Reference citation, study design and country. |
Quality assessment
Three authors (MA, ML and Bİ) independently assessed the risk of bias using the Cochrane Risk of Bias 2.0 Tool (RoB 2.0) for the included RCTs [26] and the Cochrane Tool for Risk of Bias in Non-randomised Studies (ROBINS-I) in non-RCTs [27]. The initial level of agreement between assessors was high (89%). Any discrepancies were resolved through discussion, leading to a consensus rating. Each domain was rated as ‘low risk,’ ‘high risk,’ or ‘some concerns,’ in accordance with the criteria established by the Cochrane Collaboration [28].
Data synthesis and analysis
Data were synthesised both narratively and quantitatively. Statistical analyses were conducted in R. Meta-analyses of change scores were performed when data from at least four studies were available for the same outcome. Change scores for means were calculated by subtracting baseline from post-intervention means and change scores for standard deviations were calculated assuming a correlation coefficient (r) of 0.5.
Given the clinical and methodological heterogeneity across studies, random-effects models were used with restricted maximum likelihood (REML) estimation, and standard errors were adjusted using the truncated Knapp-Hartung method. For outcomes reported in the same units across studies (weight, BMI, and waist circumference), pooled effects were expressed as mean differences (MDs). For all other outcomes, pooled effects were expressed as standardised mean differences (SMDs) using Hedges’ g to account for small sample bias. Heterogeneity was assessed using the I² statistic and Cochran’s Q test. Forest plots were generated to present effect sizes, 95% confidence intervals and study weights. Egger’s regression-based test and trim-and-fill analyses were used to assess small study effects and potential publication bias where sufficient studies were available. Crossover trials were no included in the quantitative synthesis due to likely carryover effects and insufficient period-specific outcome data.
Results
The review flowchart is presented in accordance with the PRISMA statement guidelines [25]. Figure 1 shows that out of 712 references screened, 28 studies met the inclusion criteria for the systematic review. Two studies were excluded due to duplicate populations, and one was excluded for not reporting relevant outcomes. Table 1 summarises the 28 studies included in the systematic review, of which 13 were included in the quantitative analysis.
A narrative review of the results is provided in Supplementary Material 1.
Study characteristics
The included studies involved a total of 1129 participants across both non-clinical (n = 17 studies) and clinical (n = 11 studies) populations. 14 studies (50%) recruited participants with excess body weight (i.e., BMI ≥ 25 kg/m2). The majority of studies (57%) applied tDCS as a stand-alone intervention, while three studies (10%) combined tDCS with a low-calorie diet, and seven studies (25%) incorporated cognitive-based therapies, including inhibitory control training, approach bias modification training, attention training, cognitive training, and mindful eating training. One study (4%) combined tDCS with a physical activity intervention. One study (4%) combined tDCS with intranasal oxytocin.
The number of stimulation sessions ranged from 1 to 20, with intensities of the current delivered between 1 and 2 mA and session durations varying from 7 to 40 min. Most studies (90%) employed the conventional bipolar montage, while only three studies (10%) used alternative approaches, including bi-anodal electrode placement, multichannel tDCS and net-tDCS. Stimulation sites also varied, with the dlPFC being the most commonly targeted area (60%), followed by the motor cortex (25%). Further details on the study characteristics are presented in Table 1.
Study quality
The results of the Cochrane risk of bias assessments for both between-subjects and crossover within-subjects study designs are presented in Fig. 1, see Supplementary Material 1. Across studies, the overall risk of bias was judged as low-to-moderate and the primary reason for concern was related to the non-availability of pre-published protocols. Among studies with a parallel design, the overall bias rate was rated as low in 25% of studies, whereas in 75% there were some concerns. None were assessed as high risk. Among studies with crossover design, the overall bias rate was rated as having ‘some concerns’ in 80% of studies and 20% percent were rated as ‘high concerns’.
Meta-analysis results
Meta-analyses were conducted for weight, BMI, waist circumference, Food Craving Questionnaire (FCQ) State and Trait (Figs. 2–4).
Forest plot showing mean differences with 95% confidence intervals for active transcranial direct current stimulation (tDCS) versus sham stimulation on body weight (kg).
Forest plot showing mean differences with 95% confidence intervals for active transcranial direct current stimulation (tDCS) versus sham stimulation on body mass index (BMI) (kg/m2).
Forest plot showing mean differences with 95% confidence intervals for active transcranial direct current stimulation (tDCS) versus sham stimulation on body circumference (cm).
Significant effects of real versus sham tDCS were observed for reduction in weight (MD = −2.01 kg, 95% CI: −2.82 to −1.35; p < 0.001) and waist circumference (MD = −0.67 cm, 95% CI: −1.14 to −0.19; p = 0.02), with no heterogeneity detected (I² = 0%). However, no significant effect was observed for BMI (MD = −0.13 kg/m², 95% CI: −0.35 to 0.10; p = 0.24), with no heterogeneity (I² = 0%).
No significant effect was found for state food craving (SMD = −0.19, 95% CI: −0.77 to 0.39; p = 0.42), which showed moderate heterogeneity (I² = 41%). Similarly, reductions in trait food craving favoured real tDCS but did not reach statistical significance (SMD = −0.21, 95% CI: −0.43 to 0.02; p = 0.06), with no heterogeneity (I² = 0%).
Egger’s regression test revealed no evidence of publication bias for weight (p = 0.68) and BMI (p = 0.85). Trim-and-fill analysis imputed three studies for weight, with the adjusted effect estimate remaining significant (MD = −2.18, 95% CI: −2.88 to −1.47, p < 0.001). For BMI, no studies were imputed (k = 0). Publication bias assessment was not conducted for other outcomes due to insufficient studies (k < 10).
Sensitivity analyses were conducted in relation to participants’ weight status (overweight/obesity) and the results remained consistent. For details on meta-analysis results, see Supplementary Material 1.
Sensitivity analyses excluding Fassini et al. (2020), due to its large influence on the pooled estimate, resulted in a loss of statistical significance in the meta-analysis of real versus sham tDCS for weight reduction (MD = −1.68 kg; 95% CI − 3.68 to 0.33; p < 0.10) (Supplementary Material 2). This is likely due to Fassini et al.’s paper contributing to a large effect to the pooled estimate. Once the study was removed from the analysis, the pooled mean difference reduced and the confidence interval widened, crossing zero. Heterogeneity remained negligible (I² = 0%), indicating the loss of significance reflects a reduced pooled effect/precision rather than increased between-study variance. For detailed meta-analysis results, see Supplementary Material 2.
Discussion
This systematic review and meta-analysis investigated the effects of tDCS on metabolic syndrome parameters, comparing active and sham stimulation in RCTs involving adults. It synthesised data from 1129 participants across 28 studies conducted in 10 countries. To our knowledge, it is the first such comprehensive review. It replicates reported tDCS effects on weight loss and extends these findings to include a reduction in waist circumference.
Our meta-analyses found that active tDCS significantly reduced body weight (MD = −1.16 kg, p = 0.04) and waist circumference (MD = −0.67 cm, p = 0.02) compared to sham. No significant effect was observed for BMI, blood pressure, state food craving or trait food craving (p = 0.06).
Although the outcomes for weight loss and waist circumference are statistically significant, changes were small, and therefore their clinical significance may be limited. Future RCTs should report percentage of weight change to allow clinical significance assessment and establishment of tDCS optimal dose.
Results from individual studies support the need for research on the effects of tDCS on glucose, insulin, blood pressure, food intake and mood in adults.
The weight of the study by Fassini et al. (2020), together with its narrower confidence intervals, suggest that the estimated effect on body weight reduction was more precise than that reported by the other included studies. As a result, despite its relatively small sample size, this study had a greater influence on the overall pooled effect estimate in the meta-analysis. Although its sample size was comparable to several of the other included studies, the lower variability of its findings resulted in a substantially higher study weight under the inverse-variance weighting approach.
Several factors may explain the greater precision observed in this study. Participants had a higher baseline BMI and received a more intensive intervention, consisting of 16 sessions of tDCS combined with a hypocaloric diet, which may have produced a more consistent treatment response. In addition, the study included only young adult females, resulting in a more homogeneous sample than those of the other included studies. Together, these characteristics may have reduced variability in the outcomes and contributed to the narrower confidence intervals and greater statistical weight. However, these explanations are speculative and should be interpreted with caution.
Although adverse effects are generally considered important outcomes to monitor to ensure participant safety and intervention acceptability [29], many of the included studies did not report any adverse events. This lack of reporting highlights the need for more consistent documentation of adverse effects in future studies.
Body weight, BMI, waist circumference and eating-related behaviours
Our results are in accord with those from a meta-analysis by Alhindi et al. [22], which included only individuals who were overweight or had obesity. These authors found comparable weight loss (MD = −0.82 kg, 95% CI − 1.01 to −0.62), which was also not translated into significant reductions in BMI. However, in their meta-analysis Alhindi et al. [22], five of the eleven studies included, combined tDCS with a low-calorie diet, thus complicating interpretation of tDCS-specific effects on weight. Therefore, definitive conclusions on tDCS’ effects on weight cannot be drawn, and research that isolates the effect of tDCS and lifestyle interventions is needed. As weight may be more sensitive for detecting smaller or earlier effects of tDCS than BMI, we suggest that authors report pre- and post-tDCS intervention outcomes for both parameters in future studies. Furthermore, studies should report percentage of weight loss to allow assessment of clinical efficacy and comparability of outcomes between studies.
While the significant pooled effect for waist circumference is unlikely to be clinically meaningful, due to the small number of studies (k = 4), it may suggest a favourable directional trend. Waist circumference is an accessible and affordable measure which can be valuable for assessing treatment effects. A reduction in waist circumference is an important step towards reducing the risk for cardiometabolic disease [30]. This finding is timely and important. Rubino, Cummings [31] have proposed the use of BMI as a population-level measure, together with the incorporation of at least one anthropometric assessment (e.g., waist circumference) to assess health risk associated with body fat excess.
We observed a non-significant reduction in trait-based food cravings following tDCS, consistent with findings reported in previous meta-analyses of Alhindi et al. [22]. Of note, their meta-analysis included only studies targeting the dorsolateral prefrontal cortex (dlPFC), a region frequently implicated in inhibitory control over food-related impulses Meng et al. [32]. Consistent with these findings, Mostafavi et al. [33] reported a significant medium-sized reduction in food cravings following active tDCS (over the dlPFC), compared to sham stimulation. Furthermore, a meta-analysis by Zheng et al. [21] reported a moderate effect size favouring active tDCS over the dlPFC relative to sham. Their analyses also indicated stronger effects of tDCS when it was delivered in multi-session protocols compared to single-session applications, and also, a greater reduction in food cravings and consumption among individuals who were overweight or had obesity. These findings reinforce the idea that specific protocol characteristics and participant profiles are critical in determining treatment efficacy and may partly explain the variability observed between reviews.
Blood pressure
The present findings are partially in accord with earlier studies. A recent meta-analysis by Silva-Filho, Gramile Silva Meira [14], which pooled four studies, found non-significant reductions in both systolic and diastolic blood pressure following tDCS in individuals with hypertension. In our meta-analysis, there were insufficient numbers of studies to confirm the positive outcomes reported in individual trials by Ministro, Castaño [34] and Silva-Filho, Albuquerque [35]. It is of note that these individual trials recruited only participants with diagnosed hypertension, highlighting the potential importance of target population characteristics in modulating tDCS efficacy for blood pressure outcomes. In light of the reported outcomes, tDCS may have promise for improving blood pressure regulation. However, the underlying mechanisms remain poorly understood, and further high-quality trials which are not limited to individuals with hypertension, but also to those at risk of metabolic syndrome, are needed to validate these preliminary findings [16].
Research and clinical implications
Metabolic syndrome and obesity are complex biopsychosocial conditions. Brain stimulation research for eating and weight disorders is relatively new and limited by small RCTs that typically focus on a single dimension, and thus do not capture the multifaceted nature of these conditions. While tDCS effects on mood are established in depression [36], we have shown that evidence for its use in weight management and eating disorder trials is still emerging. At present, data on biological and psychological markers is limited. Future trials should incorporate metabolic (e.g., glucose, insulin, lipid profiles), stress-related (e.g., cortisol), psychological (e.g., mood), and cognitive (e.g., memory, impulsivity) assessments to elucidate how tDCS modulates eating behaviour and body weight.
Research on tDCS has demonstrated that therapeutic efficacy is often enhanced when stimulation is applied concurrently with disorder-relevant cognitive or behavioural tasks that engage the targeted brain regions [37, 38]. Additionally, repeated sessions of tDCS have been associated with cumulative neuroplastic effects and longer-lasting modifications in brain function [12]. Individual differences also appear to moderate responsiveness to neuromodulation; for example, individuals without behavioural trait susceptibilities, such as tendencies towards overconsumption or high cravings, may exhibit reduced responsiveness to such interventions [39]. However, few studies in this review incorporated such information. Of the 28 included studies, only seven (25%) combined tDCS with cognitive or behavioural tasks, and 14 studies (50%) included participants with overweight or obesity, who may be more responsive to interventions targeting eating behaviours or metabolic dysfunction.
These methodological limitations may have contributed to the variability and substantial heterogeneity across the studies, including variation in stimulation parameters (current intensity, stimulation site and montage, and the number and duration of sessions), differences in whether tDCS was delivered as a stand-alone intervention or combined with adjunct treatments (such as cognitive-based therapies, dietary interventions, or physical activity programmes), the diversity of outcome measures employed, and the inclusion of very diverse clinical and non-clinical populations. Therefore, the findings of this meta-analysis do not allow firm conclusions on the efficacy of tDCS for improving metabolic syndrome-related outcomes. Future research should prioritise the development of standardised stimulation protocols and consistent outcome measures to reduce heterogeneity and better clarify the therapeutic potential of tDCS.
Based on the evidence, we propose that tDCS positively influences problematic eating behaviour patterns in adults, especially those who are overweight or have obesity. However, sustained and healthy weight loss, particularly that which relies on changes in eating behaviours, typically requires extended periods to evaluate. In the context of the increasing availability of GLP-based pharmacotherapies, there is a critical need to integrate sustained behavioural support to maintain treatment benefits [40]. To establish long-term effects of tDCS, future RCTs following CONSORT guidelines with adequately powered-sample sizes are needed. Such studies should assess multi-session tDCS protocols in combination with concurrent disorder-relevant cognitive intervention, with and without treatment as usual (e.g., pharmacological, lifestyle, or surgical interventions). Studies should specifically recruit individuals with a tendency toward disordered eating behaviours and overweight/obesity, employing consistent, comparable outcome measurements. Evidence suggests that targeting the right dlPFC with 20 min 2 mA anodal stimulation may offer superior outcomes for obesity related outcomes [22, 41]. Clinical studies might include the use of tDCS in enhancing long-term physical and mental health outcomes of medical interventions, such as bariatric surgery Rösch, Wünsche [42] and use of GLP-1 receptor agonists.
Strengths and limitations
This review has several strengths, notably the inclusion of a broad range of metabolic syndrome-related outcomes and the integration of narrative synthesis and quantitative meta-analyses to allow a balanced interpretation of the evidence. We report significant effects of tDCS on body weight reduction and waist circumference, identify gaps in the literature and provide recommendations for future studies. Some limitations are acknowledged. Inclusion of studies which combined tDCS with low-calorie diet/weight loss/obesity treatment prevented the isolation of tDCS effects on metabolic syndrome parameters. Secondly, adding adjunct weight-management intervention as a covariate in the meta-analyses was not possible due to the small number of studies. Inclusion of participants with or without overweight/obesity may not reflect baseline clinical characteristics of individuals with metabolic syndrome and overweight/obesity, thus our findings cannot be generalised to this population. Significant heterogeneity in study designs, stimulation protocols, populations studied and participants’ clinical characteristics, and outcome measures, constrain the strength of conclusions that can be drawn. Due to the relatively small number of eligible studies for meta-analyses, sensitivity analyses were conducted to attenuate these limitations, which showed consistent results. Finally, to avoid introducing carrying over effects bias of crossover trials, these studies were not included in the meta-analysis, and our meta-analysis evidence does not include those effects.
Conclusions
This systematic-review and meta-analyses found that tDCS significantly reduced body weight and waist circumference in adults. Individual studies reported promising findings on metabolic syndrome-related outcomes, but heterogeneity in study protocols, stimulation parameters, brain targets, and participant characteristics likely contributed to inconsistent results.
Large, well-powered confirmatory RCTs are needed, recruiting participants based on clinical and behavioural risk profiles. These should integrate tDCS with disorder-relevant cognitive or behavioural tasks, adopt multi-session protocols, and employ standardised stimulation parameters and outcome measures to enable replication. Until such evidence is available, conclusions regarding tDCS efficacy for metabolic syndrome-related outcomes should be made with caution.
Data availability
Data sets can be supplied by the corresponding author upon reasonable request.
References
Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diab Care. 2001;24:683–9.
Cornier M-A, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The metabolic syndrome. Endocr Rev. 2008;29:777–822.
Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20:12.
Alberti G, Zimmet P, Shaw J. Metabolic syndrome a new world-wide definition. a consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.
Liang X, Or B, Tsoi MF, Cheung CL, Cheung BMY. Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011–18. Postgrad Med J. 2023;99:985–92.
Ng M, Dai X, Cogen RM, Abdelmasseh M, Abdollahi A, Abdullahi A, et al. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. Lancet. 2024;404:2278–98.
Fornari E, Maffeis C. Treatment of metabolic syndrome in children. Front Endocrinol. 2019;10:702.
Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, Ndumele CE, et al. Metabolic syndrome. Nat Rev Dis Prim. 2024;10:77.
Zeng BY, Zeng BS, Chen YW, Hung CM, Sun CK, Cheng YS, et al. Efficacy and acceptability of noninvasive brain stimulation interventions for weight reduction in obesity: a pilot network meta-analysis. Int J Obes. 2021;45:1705–16.
Liu A, Vöröslakos M, Kronberg G, Henin S, Krause MR, Huang Y, et al. Immediate neurophysiological effects of transcranial electrical stimulation. Nat Commun. 2018;9:5092.
Makovac E, Thayer F, Ottaviani C. A meta-analysis of non-invasive brain stimulation and autonomic functioning: implications for brain-heart pathways to cardiovascular disease. Neurosci Biobehav Rev. 2017;74:330–41.
Moffa AH, Brunoni AR, Nikolin S, Loo CK. Transcranial direct current stimulation in psychiatric disorders: a comprehensive review. Psychiatr Clin North Am. 2018;41:447–63.
Kekic M, Boysen E, Campbell IC, Schmidt U. A systematic review of the clinical efficacy of transcranial direct current stimulation (tDCS) in psychiatric disorders. J Psychiatr Res. 2016;74:70–86.
Silva-Filho E, Gramile Silva Meira Q, Da Costa Rodrigues A, Louise Fontes Marques C, Oliveira P et al. Transcranial direct current stimulation on hypertension: a systematic review and meta-analysis. Acta Cardiol. 2024:1–10.
Araujo C, Fitz RC, da Natividade GR, Osório AF, Merello PN, Mesquita LA, et al. Effects of transcranial direct current stimulation associated with hypocaloric diet on glucose homeostasis in obesity. Obesity. 2022;30:2414–23.
Ruberti OM, Junior HM, Rodrigues B. Exploring the role of prefrontal cortex tDCS in hypertension: a mini-review. Cardiovasc Hematol Disord Drug Targets. 2024;24:201–10.
Ester T, Kullmann S. Neurobiological regulation of eating behavior: evidence based on non-invasive brain stimulation. Endocr Metab Disord. 2022;23:753–72.
Wiegand A, Sommer A, Nieratschker V, Plewnia C. Improvement of cognitive control and stabilization of affect by prefrontal transcranial direct current stimulation (tDCS). Sci Rep. 2019;9:6797.
Schroeder PA, Schwippel T, Wolz I, Svaldi J. Meta-analysis of the effects of transcranial direct current stimulation on inhibitory control. Brain Stimul. 2020;13:1159–67.
Ray MK, Sylvester MD, Osborn L, Helms J, Turan B, Burgess EE, et al. The critical role of cognitive-based trait differences in transcranial direct current stimulation (tDCS) suppression of food craving and eating in frank obesity. Appetite. 2017;116:568–74.
Zheng L, Yu Y, Wu X, Hu J, Gan Y. Effective non-invasive brain stimulation over dorsolateral prefrontal cortex for modulation of food craving and consumption: a systematic and meta-analytic review. Prog Neuro-Psychopharmacol Biol Psychiatry. 2025;137:111271.
Alhindi Y, Khalifa N, Al-Khyatt W, Idris I. The use of non-invasive brain stimulation techniques to reduce body weight and food cravings: a systematic review and meta-analysis. Clin Obes. 2023;13:e12611.
Yu J, Tseng P, Hung DL, Wu SW, Juan CH. Brain stimulation improves cognitive control by modulating medial-frontal activity and preSMA-vmPFC functional connectivity. Hum Brain Mapp. 2015;36:4004–15.
Strobach T, Antonenko D. tDCS-induced effects on executive functioning and their cognitive mechanisms: a review. J Cogn Enhanc. 2017;1:49–64.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343.
Knotkova H, Clayton A, Stevens M, Riggs A, Charvet LE, Bikson M. Home-based patient-delivered remotely supervised transcranial direct current stimulation. In: Knotkova H, Nitsche MA, Bikson M, Woods AJ, editors. Practical guide to transcranial direct current stimulation: principles, procedures and applications. Springer International Publishing; 2019. pp. 379–405.
Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16:177–89.
Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diab Endocrinol. 2025;13:221–62.
Meng X, Huang D, Ao H, Wang X, Gao X. Food cue recruits increased reward processing and decreased inhibitory control processing in the obese/overweight: An activation likelihood estimation meta-analysis of fMRI studies. Obesity Research & Clinical Practice. 2020;14(2):127-35.
Mostafavi S-A, Ali K, Reza MM, Akhondzadeh S. Is transcranial direct current stimulation an effective modality in reducing food craving? A systematic review and meta-analysis. Nutr Neurosci. 2020;23:55–67.
Ministro G, Castaño JB, Barboza CA, Moura EG, Ferreira-Melo SE, Mostarda CT, et al. Acute transcranial direct current stimulation (tDCS) improves ventilatory variability and autonomic modulation in resistant hypertensive patients. Respir Physiol Neurobiol. 2022;297:103830.
Silva-Filho E, Albuquerque J, Bikson M, Pegado R, da Cruz Santos A, do Socorro Brasileiro-Santos M. Effects of transcranial direct current stimulation associated with an aerobic exercise bout on blood pressure and autonomic modulation of hypertensive patients: a pilot randomized clinical trial. Auton Neurosci. 2021;235:102866.
Zheng EZ, Wong NML, Yang ASY, Lee TMC. Evaluating the effects of tDCS on depressive and anxiety symptoms from a transdiagnostic perspective: a systematic review and meta-analysis of randomized controlled trials. Transl Psychiatry. 2024;14:295.
Sathappan AV, Luber BM, Lisanby SH. The dynamic duo: combining noninvasive brain stimulation with cognitive interventions. Prog Neuropsychopharmacol Biol Psychiatry. 2019;89:347–60.
Boroda E, Sponheim SR, Fiecas M, Lim KO. Transcranial direct current stimulation (tDCS) elicits stimulus-specific enhancement of cortical plasticity. Neuroimage. 2020;211:116598.
Beaumont JD, Smith NC, Starr D, Davis D, Dalton M, Nowicky A, et al. Modulating eating behavior with transcranial direct current stimulation (tDCS): a systematic literature review on the impact of eating behavior traits. Obes Rev. 2022;23:e13364.
Holm S, Tena-Sempere M, Koutsouris D, Dedoussis GV, Wagner K-H, Arranz S, et al. The case for primary prevention of obesity in the era of GLP-1 therapies. Lancet Reg Health – Europe. 2026;66:101679.
Chen J, Qin J, He Q, Zou Z. A meta-analysis of transcranial direct current stimulation on substance and food craving: what effect do modulators have? Front Psychiatry. 2020;11:598.
Rösch SA, Wünsche L, Thiele C, Reinstaller T, Zähle T, Schag K, et al. Enhancing the outcomes of bariatric surgery with inhibitory control training, electrical brain stimulation and psychosocial aftercare: a pilot study protocol. J Eat Disord. 2024;12:202.
Ageeli M, Flynn M, Lopes M, İnce B, Alves D, Westwood SJ, et al. A feasibility study of the effects of concurrent transcranial direct current stimulation (tDCS) on mindfulness training in adults living with overweight or obesity: the MINDED trial protocol. Pilot and Feasibility Studies, 2026;12(1):19. https://doi.org/10.1186/s40814-025-01748-9.
Araújo de Oliveira Figueirêdo H, Silva-Filho E, Felipe Cavalcante A, Pegado R, Cecília Queiroz de Medeiros A. Transcranial direct current stimulation for food craving in women affected by overweight and obesity: A randomized controlled trial. Eur Addict Res, 2024;30(4):197–206. https://doi.org/10.1159/000535720.
Aslaksen PM, Vasylenko O, Fagerlund AJ. The effect of transcranial direct current stimulation on experimentally induced heat pain. Experimental Brain Research, 2014;232(6):1865–1873. https://doi.org/10.1007/s00221-014-3878-0.
Bernardes TS, Santos KCS, Nascimento MR, Filho C, Bazan R, Pereira JM, et al. Effects of anodal transcranial direct current stimulation over motor cortex on resting-state brain activity in the early subacute stroke phase: A power spectral density analysis. Clin Neurol Neurosurg, 2024;237:108134. https://doi.org/10.1016/j.clineuro.2024.108134.
Binkofski F, Loebig M, Jauch-Chara K, Bergmann S, Melchert UH, Scholand-Engler HG, et al. Brain energy consumption induced by electrical stimulation promotes systemic glucose uptake. Biol Psychiatry, 2011;70(7):690–695. https://doi.org/10.1016/j.biopsych.2011.05.009
Chang CC, Kao YC, Chao CY, Tzeng NS, Chang HA. Examining bi-anodal transcranial direct current stimulation (tDCS) over bilateral dorsolateral prefrontal cortex coupled with bilateral extracephalic references as a treatment for negative symptoms in non-acute schizophrenia patients: A randomized, double-blind, sham-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry, 2020;96:109715. https://doi.org/10.1016/j.pnpbp.2019.109715.
Ester-Nacke T, Veit R, Thomanek J, Book M, Tamble L, Beermann M, et al. Repeated net-tDCS of the hypothalamus appetite-control network enhances inhibitory control and decreases sweet food intake in persons with overweight or obesity. Brain Stimul, 2025;18(3):863–874. https://doi.org/10.1016/j.brs.2025.04.013.
Fassini PG, Das SK, Magerowski G, Marchini JS, da Silva Junior WA, da Silva IR, et al. Noninvasive neuromodulation of the prefrontal cortex in young women with obesity: a randomized clinical trial. Int J Obes (Lond), 2020;44(6):1279–1290. https://doi.org/10.1038/s41366-020-0545-3.
Flynn M, Campbell IC, Schmidt U. Concurrent self-administered transcranial direct current stimulation and attention bias modification training in binge eating disorder: feasibility randomised sham-controlled trial. BJPsych Open, 2024;10(4):e118. https://doi.org/10.1192/bjo.2024.54.
Forcano L, Castellano M, Cuenca-Royo A, Goday-Arno A, Pastor A, Langohr K, et al. Prefrontal cortex neuromodulation enhances frontal asymmetry and reduces caloric intake in patients with morbid obesity. Obesity, 2020;28(4):696–705. https://doi.org/10.1002/oby.22745.
Giel KE, Schag K, Max SM, Martus P, Zipfel S, Fallgatter AJ. et al. Inhibitory control training enhanced by transcranial direct current stimulation to reduce binge eating episodes: Findings from the randomized phase II ACCElect trial. Psychother Psychosom, 2023;92(2):101–112. https://doi.org/10.1159/000529117.
Gordon, G. An investigation into concurrent approach bias modification training and transcranial direct current stimulation for binge eating disorder (PhD thesis). King’s College London. 2021.
Hamner JW, Villamar MF, Fregni F, Taylor JA. Transcranial direct current stimulation (tDCS) and the cardiovascular responses to acute pain in humans. Clin Neurophysiol, 2025;126(5):1039–1046. https://doi.org/10.1016/j.clinph.2014.08.019.
Heinitz S, Reinhardt M, Piaggi P, Weise CM, Diaz E, Stinson EJ, et al. Neuromodulation directed at the prefrontal cortex of subjects with obesity reduces snack food intake and hunger in a randomized trial. Am J Clin Nutr, 2017;106(6):1347–1357. https://doi.org/10.3945/ajcn.117.158089.
Jauch-Chara K, Kistenmacher A, Herzog N, Schwarz M, Schweiger U, Oltmanns KM. Repetitive electric brain stimulation reduces food intake in humans. Am J Clin Nutr, 2014;100(4):1003–1009. https://doi.org/10.3945/ajcn.113.075481.
Jornada MND, Antunes LC, Alves C, Torres ILS, Fregni F, PR SS, et al. Impact of multiple-session home-based transcranial direct current stimulation (M-HB-tDCS) on eating behavior in fibromyalgia: A factorial randomized clinical trial. Brain Stimul, 2024;17(2):152–162. https://doi.org/10.1016/j.brs.2024.02.001.
Kistenmacher A, Manneck S, Wardzinski EK, Martens JC, Gohla G, Melchert U. H, et al. Persistent blood glucose reduction upon repeated transcranial electric stimulation in men. Brain Stimulation, 2017;10(4):780–786. https://doi.org/10.1016/j.brs.2017.03.011.
Ljubisavljevic M, Maxood K, Bjekic J, Oommen J, Nagelkerke N. (2016). Long-term effects of repeated prefrontal cortex transcranial direct current stimulation (tDCS) on food craving in normal and overweight young adults. Brain Stimulation, 2016;9(6):826–833. https://doi.org/10.1016/j.brs.2016.07.002.
Lopes M, Monssen D, Grycuk L, Gordon G, Gaughran F, Campbell IC, Schmidt U. Combining cognitive training and brain stimulation: A novel approach to address disordered eating and antipsychotic-induced weight gain in people with severe mental illness. Early Interv Psychiatry. 2026;20(11):e70275. https://doi.org/10.1111/eip.70275
Mehranpour A, Eskandari Z, Hejazi J, Gazori T, Saboory E. The effect of transcranial direct current stimulation (tDCS) and oxytocin on food craving and weight control in obese individuals with food addiction: a double-blind clinical trial. Int J Neurosci, 2026;136(2):189–201. https://doi.org/10.1080/00207454.2025.2523323.
Miler JA, Meron D, Baldwin DS, Garner M. The effect of prefrontal transcranial direct current stimulation on attention network function in healthy volunteers. Neuromodulation, 2018;21(4):355–361. https://doi.org/10.1111/ner.12629.
Ministro G, Castaño JB, Barboza CA, Moura EG, Ferreira-Melo SE, Mostarda CT, et al. Acute transcranial direct current stimulation (tDCS) improves ventilatory variability and autonomic modulation in resistant hypertensive patients. Respir Physiol Neurobiol, 2022;297:103830. https://doi.org/10.1016/j.resp.2021.103830.
Montoro CI, Ruiz-Medina P, Duschek S, Gutiérrez-Palma N, Reyes Del Paso GA. Bilateral tDCS over the DLPFC enhances baroreceptor reflex sensitivity and inhibits blood pressure-related hypoalgesia. Clin Neurophysiol, 2025;169:11–22. https://doi.org/10.1016/j.clinph.2024.11.011.
Pegado R, Melo M, Oehmen T, Kirsztajn GM, Silva-Filho E, Quintiliano A. Safety and feasibility of transcranial direct current stimulation in end-stage renal disease patients undergoing hemodialysis: an exploratory study. J Bras Nefrol, 2024;46(4):e20240010. https://doi.org/10.1590/2175-8239-JBN-2024-0010en.
Usanos C, Valenzuela PL, de la Villa P, Navarro SM, Melo Aroeira AE, Amo Usanos I, et al. Neuromodulation of the prefrontal cortex facilitates diet-induced weight loss in midlife women: A randomized, proof-of-concept clinical trial. Int J Obes (Lond), 2020;44(3):568–578. https://doi.org/10.1038/s41366-019-0486-x.
Vandermeeren Y, Jamart J, Ossemann M. Effect of tDCS with an extracephalic reference electrode on cardio-respiratory and autonomic functions. BMC Neurosci, 2010;11:38. https://doi.org/10.1186/1471-2202-11-38.
Acknowledgements
We would like to thank Carla Dirmina for her thoughtful input and collaboration.
Funding
MA is financially supported by Ministry of Education of Saudi Arabia. This research was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at the South London and Maudsley. NHS Foundation Trust (SlaM) and Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King’s College London (KCL). US receives salary support from the NIHR BRC for Mental Health at SlaM and KCL. The opinions expressed in this publication are those of the authors and not necessarily those of the National Health Service, the NIHR or the UK Department of Health. The funder did not participate in the writing of this the review.
Author information
Author notes
These authors contributed equally: Manar Ageeli, Mariana Lopes.
Authors and Affiliations
Centre for Research in Eating and Weight Disorders (CREW), Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London, London, UK
Manar Ageeli, Mariana Lopes, Başak İnce, Iain C. Campbell & Ulrike Schmidt
South London and Maudsley NHS Foundation Trust, London, UK
Ulrike Schmidt
Authors
- Manar Ageeli
- Mariana Lopes
- Başak İnce
- Iain C. Campbell
- Ulrike Schmidt
Contributions
MA drafted the initial manuscript. ML conducted the meta-analysis and performed the statistical analyses. MA and ML were involved in study selection, data extraction, and interpretation of the findings. US, IC, ML and BI critically reviewed and revised the manuscript. All authors approved the final version of the manuscript.
Corresponding author
Correspondence to Manar Ageeli.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ageeli, M., Lopes, M., İnce, B. et al. A systematic review and meta-analysis exploring the effects of tDCS on metabolic syndrome parameters in adults. Int J Obes (2026). https://doi.org/10.1038/s41366-026-02242-9
Received: 24 April 2026
Revised: 10 September 2026
Accepted: 29 September 2026
Published: 16 November 2026
Version of record: 16 November 2026
DOI: https://doi.org/10.1038/s41366-026-02242-9
来源:Nature 健康护理主题 · nature.com